Jay Hoon Ryu
Impact in
- Pulmonary and Respiratory Medicine top 0.01%
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Medical Imaging and Pathology Studies
- Respiratory and Cough-Related Research
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Pleural and Pulmonary Diseases
- Occupational and environmental lung diseases
- Physiology top 0.05%
- Sarcoidosis and Beryllium Toxicity Research
- Tuberous Sclerosis Complex Research
Papers in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 200
- Medical Imaging and Pathology Studies 51
- Respiratory and Cough-Related Research 30
- Physiology 132
- Sarcoidosis and Beryllium Toxicity Research 50
- Histiocytic Disorders and Treatments 45
- Tuberous Sclerosis Complex Research 25
- Co-authors
- Thomas E. Hartman (36 shared papers)Robert Vassallo (49 shared papers)Jeffrey L. Myers (22 shared papers)Eunhee S. Yi (70 shared papers)Darrell R. Schroeder (13 shared papers)Paul A. Decker (28 shared papers)Eric L. Matteson (22 shared papers)Henry D. Tazelaar (22 shared papers)
- Journals
- CHEST Journal (115 papers)Mayo Clinic Proceedings (57 papers)Respiratory Medicine (27 papers)American Journal of Respiratory and Critical Care Medicine (21 papers)European Respiratory Journal (13 papers)
- Partner nations
- United StatesItalyUnited Kingdom
In The Last Decade
Jay Hoon Ryu
468 papers receiving 39.2k citations
Jay Hoon Ryu's Hit Papers
Peers
Comparison fields: 5 of 165
- Pulmonary and Respiratory Medicine 28.1k
- Physiology 10.6k
- Rheumatology 4.4k
- Internal Medicine 578
- Epidemiology 5.0k
Countries citing papers authored by Jay Hoon Ryu
This map shows the geographic impact of Jay Hoon Ryu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay Hoon Ryu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay Hoon Ryu more than expected).
Fields of papers citing papers by Jay Hoon Ryu
This network shows the impact of papers produced by Jay Hoon Ryu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay Hoon Ryu. The network helps show where Jay Hoon Ryu may publish in the future.
Co-authors
The 25 scholars most cited alongside Jay Hoon Ryu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 487 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management Hit paper breakdown → | 2011 | 5886 |
| 2 | An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias Hit paper breakdown → | 2013 | 3255 |
| 3 | A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis Hit paper breakdown → | 2012 | 1018 |
| 4 | Acute Exacerbations of Idiopathic Pulmonary Fibrosis Hit paper breakdown → | 2007 | 932 |
| 5 | Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis Hit paper breakdown → | 1998 | 889 |
| 6 | Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper Hit paper breakdown → | 2017 | 787 |
| 7 | International Consensus Guidance Statement on the Management and Treatment of IgG4‐Related Disease Hit paper breakdown → | 2015 | 745 |
| 8 | Incidence and mortality of interstitial lung disease in rheumatoid arthritis: A population‐based study Hit paper breakdown → | 2010 | 681 |
| 9 | Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease Hit paper breakdown → | 2009 | 476 |
| 10 | 2001 | 452 | |
| 11 | Incidence, Prevalence, and Clinical Course of Idiopathic Pulmonary Fibrosis Hit paper breakdown → | 2009 | 424 |
| 12 | MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease Hit paper breakdown → | 2018 | 397 |
| 13 | 2005 | 354 | |
| 14 | 1990 | 352 | |
| 15 | 2005 | 347 | |
| 16 | 2000 | 345 | |
| 17 | 2011 | 341 | |
| 18 | Classification of Cough as a Symptom in Adults and Management Algorithms Hit paper breakdown → | 2017 | 314 |
| 19 | 2002 | 304 | |
| 20 | 2015 | 281 |
About Jay Hoon Ryu
Jay Hoon Ryu is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Rheumatology, Epidemiology and Surgery, having authored 487 papers that have together received 41.2k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (200 papers), Medical Imaging and Pathology Studies (51 papers), Sarcoidosis and Beryllium Toxicity Research (50 papers), Histiocytic Disorders and Treatments (45 papers), Respiratory and Cough-Related Research (30 papers), Tuberous Sclerosis Complex Research (25 papers), IgG4-Related and Inflammatory Diseases (21 papers) and Neuroendocrine Tumor Research Advances (17 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (28.1k citations), Physiology (10.6k citations), Rheumatology (4.4k citations), Internal Medicine (578 citations) and Epidemiology (5.0k citations). Jay Hoon Ryu has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Thomas E. Hartman, Robert Vassallo, Jeffrey L. Myers, Eunhee S. Yi, Darrell R. Schroeder, Paul A. Decker, Eric L. Matteson, Henry D. Tazelaar, Thomas Vail Colby and Craig E Daniels. Their work appears in journals such as CHEST Journal, Mayo Clinic Proceedings, Respiratory Medicine, American Journal of Respiratory and Critical Care Medicine and European Respiratory Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.